+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type (Multi-Use, Single-Use), By Mode, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 145 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 4871376
Description Jump to:
The global upstream bioprocessing market size is expected to reach USD 59.1 billion by 2030, expanding at a CAGR of 16.6% from 2023 to 2030. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher’s market presence with the addition of GE Biopharma’s cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Upstream Bioprocessing Market Report Highlights

  • High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
  • Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
  • Outsourced mode of upstream bioprocessing is anticipated to witness the fastest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
  • North America dominated the global upstream bioprocessing market as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
  • Asia Pacific is poised to witness the fastest CAGR over the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Workflow
1.1.3. Use Type
1.1.4. Mode
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Workflow outlook
2.2.3. Use type outlook
2.2.4. Mode outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Upstream Bioprocessing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Upstream Bioprocessing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Upstream Bioprocessing: Product Estimates & Trend Analysis
4.1. Upstream Bioprocessing Market: Key Takeaways
4.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Bioreactors/Fermenters
4.3.1. Bioreactors/Fermenters market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Cell Culture Products
4.4.1. Cell culture products market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Filters
4.5.1. Filters market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Bioreactors Accessories
4.6.1. Bioreactors accessories market estimates and forecasts, 2018 to 2030 (USD Billion)
4.7. Bags & Containers
4.7.1. Bags & containers market estimates and forecasts, 2018 to 2030 (USD Billion)
4.8. Others
4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Upstream Bioprocessing: Workflow Estimates & Trend Analysis
5.1. Upstream Bioprocessing Market: Key Takeaways
5.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Media Preparation
5.3.1. Media preparation market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Cell Culture
5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Cell Separation
5.5.1. Cell separation market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Upstream Bioprocessing: Use Type Estimates & Trend Analysis
6.1. Upstream Bioprocessing Market: Key Takeaways
6.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Multi-Use
6.3.1. Multi-use market estimates and forecasts, 2018 to 2030 (USD Billion)
6.4. Single-Use
6.4.1. Single-use market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Upstream Bioprocessing: Mode Estimates & Trend Analysis
7.1. Upstream Bioprocessing Market: Key Takeaways
7.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
7.3. In-House
7.3.1. In-house market estimates and forecasts, 2018 to 2030 (USD Billion)
7.4. Outsourced
7.4.1. Outsourced market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Upstream Bioprocessing Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.7.2. Saudi Arabia
8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. GE HealthCare
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Thermo Fisher Scientific Inc.
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Merck KGaA
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Corning, Inc.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Sartorius AG
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Eppendorf AG
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Danaher
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Boehringer Ingelheim GmbH
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Applikon Biotechnology
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. PBS Biotech, Inc.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. Lonza
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
9.2.12. CellGenix GmbH
9.2.12.1. Company overview
9.2.12.2. Financial performance
9.2.12.3. Product benchmarking
9.2.12.4. Strategic initiatives
9.2.13. Samsung BioLogics
9.2.13.1. Company overview
9.2.13.2. Financial performance
9.2.13.3. Product benchmarking
9.2.13.4. Strategic initiatives
9.2.14. AGC Inc.
9.2.14.1. Company overview
9.2.14.2. Financial performance
9.2.14.3. Product benchmarking
9.2.14.4. Strategic initiatives
9.2.15. VWR International, LLC
9.2.15.1. Company overview
9.2.15.2. Financial performance
9.2.15.3. Product benchmarking
9.2.15.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 3 North America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 4 North America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 5 North America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 6 North America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 7 U.S. upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 8 U.S. upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 9 U.S. upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 10 U.S. upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 11 Canada upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 12 Canada upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 13 Canada upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 14 Canada upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 15 Europe upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 16 Europe upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 17 Europe upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 18 Europe upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 19 Europe upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 20 Germany upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 21 Germany upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 22 Germany upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 23 Germany upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 24 UK upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 25 UK upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 26 UK upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 27 UK upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 28 France upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 29 France upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 30 France upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 31 France upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 32 Italy upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 33 Italy upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 34 Italy upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 35 Italy upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 36 Spain upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 37 Spain upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 38 Spain upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 39 Spain upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 40 Sweden upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 41 Sweden upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 42 Sweden upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 43 Sweden upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 44 Norway upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 45 Norway upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 46 Norway upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 47 Norway upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 48 Denmark upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 49 Denmark upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 50 Denmark upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 51 Denmark upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 52 Asia Pacific upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 53 Asia Pacific upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 54 Asia Pacific upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 55 Asia Pacific upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 56 Asia Pacific upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 57 Japan upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 58 Japan upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 59 Japan upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 60 Japan upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 61 China upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 62 China upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 63 China upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 64 China upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 65 India upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 66 India upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 67 India upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 68 India upstream bioprocessing market, by mode (USD Billion) 2018 - 2030
Table 69 Australia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 70 Australia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 71 Australia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 72 Australia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 73 Thailand upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 74 Thailand upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 75 Thailand upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 76 Thailand upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 77 South Korea upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 78 South Korea upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 79 South Korea upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 80 South Korea upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 81 Latin America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 82 Latin America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 83 Latin America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 84 Latin America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 85 Latin America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 86 Brazil upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 87 Brazil upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 88 Brazil upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 89 Brazil upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 90 Mexico upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 91 Mexico upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 92 Mexico upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 93 Mexico upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 94 Argentina upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 95 Argentina upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 96 Argentina upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 97 Argentina upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 98 Middle East and Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 99 Middle East and Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 100 Middle East and Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 101 Middle East and Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 102 Middle East and Africa upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 103 South Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 104 South Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 105 South Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 106 South Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 107 Saudi Arabia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 108 Saudi Arabia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 109 Saudi Arabia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 110 Saudi Arabia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 111 UAE upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 112 UAE upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 113 UAE upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 114 UAE upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 115 Kuwait upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 116 Kuwait upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 117 Kuwait upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 118 Kuwait upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Upstream bioprocessing: Market outlook
Fig. 8 Upstream bioprocessing: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Upstream bioprocessing market driver impact
Fig. 14 Upstream bioprocessing market restraint impact
Fig. 15 Upstream bioprocessing market strategic initiatives analysis
Fig. 16 Upstream bioprocessing market: Product movement analysis
Fig. 17 Upstream bioprocessing market: Product outlook and key takeaways
Fig. 18 Bioreactors/Fermenters market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 19 Cell culture products market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 20 Filters market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 21 Bioreactors accessories market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Bags & containers market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Upstream bioprocessing market: Workflow movement analysis
Fig. 25 Upstream bioprocessing market: Workflow outlook and key takeaways
Fig. 26 Media preparation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Cell culture market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Cell separation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Upstream bioprocessing market: Use type movement analysis (USD Billion)
Fig. 30 Upstream bioprocessing market: Use type outlook and key takeaways
Fig. 31 Multi-use market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 32 Single-use market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Upstream bioprocessing market: Mode movement analysis
Fig. 34 Upstream bioprocessing market: Mode outlook and key takeaways
Fig. 35 In-house market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 36 Outsourced market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 Global upstream bioprocessing market: Regional movement analysis
Fig. 38 Global upstream bioprocessing market: Regional outlook and key takeaways
Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 40 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 43 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 50 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 52 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 China market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 54 India market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 56 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 58 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 60 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 62 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 64 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 65 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)

Companies Mentioned

  • GE HealthCare
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Corning, Inc.
  • Sartorius AG
  • Eppendorf AG
  • Danaher
  • Boehringer Ingelheim GmbH
  • Applikon Biotechnology
  • PBS Biotech, Inc.
  • Lonza
  • CellGenix GmbH
  • Samsung BioLogics
  • AGC Inc.
  • VWR International, LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages145
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 16.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 59.1 Billion
Compound Annual Growth Rate16.6%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Single-use Bioprocessing Probes And Sensors Market Size, Share & Trends Analysis Report By Workflow (Downstream, Upstream), By Sensor Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Single-use Bioprocessing Probes And Sensors Market Size, Share & Trends Analysis Report By Workflow (Downstream, Upstream), By Sensor Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 200 Pages
  • Global
From
Global Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Forecast 2024-2030 - Product Image

Global Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Single-use Bioprocessing Market by Function (Cell Culture, Filtration, Mixing), Product (Bioprocess Drums Liners & Accessories, Disposable Mixers, Disposable or Single-Use Bioreactors), Workflow, End-User - Forecast 2024-2030 - Product Image

Global Single-use Bioprocessing Market by Function (Cell Culture, Filtration, Mixing), Product (Bioprocess Drums Liners & Accessories, Disposable Mixers, Disposable or Single-Use Bioreactors), Workflow, End-User - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Upstream Bioprocessing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Workflow, Usage Type, Mode, and Geography - Product Image

Upstream Bioprocessing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Workflow, Usage Type, Mode, and Geography

  • Report
  • 210 Pages
  • Global
From
Single Use Bioprocessing Global Market Report 2024 - Product Image

Single Use Bioprocessing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.